Effect of CD4+CD25+ and CD4+CD25- T regulatory cells on the generation of cytolytic T cell response to a self but human tumor-associated epitope in vitro

被引:37
作者
Chattopadhyay, S [1 ]
Mehrotra, S [1 ]
Chhabra, A [1 ]
Hegde, U [1 ]
Mukherji, B [1 ]
Chakraborty, NG [1 ]
机构
[1] Univ Connecticut, Sch Med, Farmington, CT 06030 USA
关键词
D O I
10.4049/jimmunol.176.2.984
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD4(+) T cells naturally expressing CD25 molecules (natural T regulatory cells (Tregs)) have a role in maintaining self tolerance and in regulating responses to infectious agents, transplantation Ags, and tumor Ags. CD4(+) Tregs induced from CD4(+)CD25(-) precursors (induced Tregs) also regulate immune responses in the periphery. However, which of these Tregs is a major impediment in generating antitumor CTL responses is not clear. We show that although the CD4(+)CD25(+) subsets isolated from peripheral blood-derived lymphocytes do suppress the proliferation of CD4(+)CD25(-) effector T cells, they do not suppress the activation and expansion of the self but melanoma-associated, melanoma Ag-reactive T cell 1 (MART-1)(27-35)-specific CD8(+) T cells stimulated by the respective peptide-loaded matured dendritic cells in vitro. The CD4+CD25- counterparts, in contrast, lead to the generation of CD25(+) glucocorticoid-inducible TNFR+-Forkhead/winged helix transcription factor(+) populations and efficiently suppress the activation and expansion of the MART-1(27-35) epitope-specific CTLs. Our data suggest that when CTL precursors are optimally stimulated, natural Tregs are not a formidable constraint toward generating a robust antitumor CTL response, but induced Tregs could be.
引用
收藏
页码:984 / 990
页数:7
相关论文
共 60 条
[31]  
MUKHERJI B, 1986, J IMMUNOL, V136, P1888
[32]   CLONAL ANALYSIS OF CYTO-TOXIC AND REGULATORY T-CELL RESPONSES AGAINST HUMAN-MELANOMA [J].
MUKHERJI, B ;
GUHA, A ;
CHAKRABORTY, NG ;
SIVANANDHAM, M ;
NASHED, AL ;
SPORN, JR ;
ERGIN, MT .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 169 (06) :1961-1976
[33]  
Onizuka S, 1999, CANCER RES, V59, P3128
[34]   Ex vivo expanded human CD4+ regulatory NKT cells suppress expansion of tumor antigen-specific CTLs [J].
Osada, T ;
Morse, MA ;
Lyerly, HK ;
Clay, TM .
INTERNATIONAL IMMUNOLOGY, 2005, 17 (09) :1143-1155
[35]   Acquisition of anergic and suppressive activities in transforming growth factor-β-costimulated CD4+CD25- T cells [J].
Park, HB ;
Paik, DJ ;
Jang, E ;
Hong, S ;
Youn, J .
INTERNATIONAL IMMUNOLOGY, 2004, 16 (08) :1203-1213
[36]   Naturally-occurring CD4+CD25+ immunoregulatory T cells:: central players in the arena of peripheral tolerance [J].
Piccirillo, CA ;
Shevach, EM .
SEMINARS IN IMMUNOLOGY, 2004, 16 (02) :81-88
[37]   Cutting edge:: Control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cells [J].
Piccirillo, CA ;
Shevach, EM .
JOURNAL OF IMMUNOLOGY, 2001, 167 (03) :1137-1140
[38]   Type 1 T regulatory cells [J].
Roncarolo, MG ;
Bacchetta, R ;
Bordignon, C ;
Narula, S ;
Levings, MK .
IMMUNOLOGICAL REVIEWS, 2001, 182 :68-79
[39]   Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses [J].
Sakaguchi, S .
ANNUAL REVIEW OF IMMUNOLOGY, 2004, 22 :531-562
[40]   Naturally arising Foxp3-expressing CD25+ CD4+ regulatory T cells in immunological tolerance to self and non-self [J].
Sakaguchi, S .
NATURE IMMUNOLOGY, 2005, 6 (04) :345-352